FDA Inspection 1131410 — EPIMRD d.b.a. Western Sky Medical Research
The FDA completed an inspection of EPIMRD d.b.a. Western Sky Medical Research on August 20, 2020 in El Paso, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 20, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- El Paso, TX (United States)
Additional Details
Clinical BA/BE